 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
AP PHARMA INC, (APPA) Stock Rating Learn More
| Our Overall Rating on AP PHARMA INC, APPA is Not Available | | A.P. Pharma, Inc., a specialty pharmaceutical company, develops pharmaceutical products utilizing its polymer-based drug delivery systems. The company offers Retin-A Micro, a dermatological product based on Microsponge technology; and Carac, a chemotherapeutic product. It focuses on the development and commercialization of bioerodible injectable and implantable systems under the name of Biochronomer. In addition, A.P. Pharma develops APF530 product for the prevention of acute and delayed chemotherapy-induced nausea and vomiting; and APF112 product for the treatment of post-surgical pain. Its APF530 completed a phase I trial and APF112 completed Phase II human clinical trials. The company was founded as AMCO Polymerics, Inc. in 1983 and changed its name to Advanced Polymer Systems, Inc. in 1984. Further, Advanced Polymer Systems changed its name to A.P. Pharma, Inc. in 2001. A.P. Pharma is based in Redwood City, California. | | Our Not Available Rating on APPA was issued on 11/22/2008 |
AP PHARMA INC Technical Rating
|
|
|
|
